KUROS BIOSCIENCES AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.99 CHF | +0.50% |
|
-1.11% | +128.94% |
| 04-24 | Kuros Biosciences Posts Higher Q1 Product Sales | MT |
| 04-17 | Kuros Biosciences AG Approves Board of Director and Committee Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 321M | - | - | - | - | - | |
| 115B | ||||||
| 106B | ||||||
| 24.69B | - | |||||
| 21.97B | - | |||||
| 19.27B |
